Stocktoria
Prestige Consumer Healthcare Inc. PBH
NYSE · XNYS · stock · Pharmaceutical Preparations · website · IPO 2005-02-10
Prestige Consumer Healthcare Inc. financials (annual, from 10-K)
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $1.1B | $1.1B | $1.1B | $1.1B | $1.1B |
| Gross profit | $595.6M | $634.5M | $624.4M | $625.3M | $620.6M |
| Operating income | $309.4M | $336.8M | $342.4M | -$22.4M | $329.9M |
| Interest expense | — | $1.8M | $5.2M | $4.4M | — |
| Income tax | $67.2M | $69.6M | $66.7M | -$11.6M | $57.1M |
| Net income | $190.3M | $214.6M | $209.3M | -$82.3M | $205.4M |
| EPS (diluted) | $3.91 | $4.29 | $4.17 | $-1.65 | $4.04 |
| Operating cash flow | $257.6M | $251.5M | $248.9M | $229.7M | $259.9M |
| Free cash flow | $246.4M | $243.3M | $239.4M | $221.9M | $250.3M |
| Cash & equivalents | $63.9M | $97.9M | $46.5M | $58.5M | $27.2M |
| Inventory | $159.1M | $147.7M | $138.7M | $162.1M | $120.3M |
| Total assets | $3.5B | $3.4B | $3.3B | $3.4B | $3.7B |
| Total liabilities | $1.6B | $1.6B | $1.7B | $1.9B | $2.1B |
| Shareholders' equity | $1.9B | $1.8B | $1.7B | $1.4B | $1.6B |
Source: SEC EDGAR filings · CIK 0001295947 · as of 2026-03-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.